Cal. Code Regs. tit. 17 § 3000.2

Current through Register 2024 Notice Reg. No. 45, November 8, 2024

Section 3000.2 - Botulism Immune Globulin

"Botulism Immune Globulin" or "BIG" means the pharmaceutical product which consists of human-derived or human-gene-derived immunoglobulin (antibody) molecules or active fragments thereof and appropriate stabilizing agents that possesses the ability to neutralize botulinum or botulinum-like toxins.

Cal. Code Regs. Tit. 17, § 3000.2

1. New subchapter 4 (articles 1-4), article 1 (sections 3000.2-3000.4) and section filed 6-3-98 as an emergency; operative 6-3-98 (Register 98, No. 23). A Certificate of Compliance must be transmitted to OAL by 10-1-98 or emergency language will be repealed by operation of law on the following day.
2. Certificate of Compliance as to 6-3-98 order transmitted to OAL 9-23-98 and filed 11-4-98 (Register 98, No. 45).

Note: Authority cited: Section 123707(c), Health and Safety Code. Reference: Sections 123700- 123709, Health and Safety Code.

1. New subchapter 4 (articles 1-4), article 1 (sections 3000.2-3000.4) and section filed 6-3-98 as an emergency; operative 6-3-98 (Register 98, No. 23). A Certificate of Compliance must be transmitted to OAL by 10-1-98 or emergency language will be repealed by operation of law on the following day.
2. Certificate of Compliance as to 6-3-98 order transmitted to OAL 9-23-98 and filed 11-4-98 (Register 98, No. 45).